Achromatopsia - a genetic visual disorder that effects about 1 out of every 33,000 Americans - leads to severe vision problems, generally beginning at a young age. People with this disorder are extremely sensitive to light, have trouble seeing during the day (when it is bright out) and cannot see any color.Read More
- $441 million in annual NIH funding
- $117 million in funding for the creation of two new medical buildings
- A potential of more than $125,000 from sales leads
- "Fantastic experience. Great people, great connections, great food, great show!!"
READ MORE BELOW:
Situated in Upper Manhattan, in the busy, bustling city of New York, Columbia University attracts a wide variety of highly intelligent students and researchers to its world-class facilities. Within the four main graduate schools in the Columbia Medical Center (College of Physicians and Surgeons, College of Dental Medicine, Mailman School of Public Health, School of Nursing), hundreds of researchers work in the different research facilities to find new knowledge and develop therapies to improve public health in New York and around the world.Read More
Glioblastoma is the most aggressive form of brain cancer, and like many other cancers, its causes are still unknown. Since it is generally very malignant, researchers know that glioblastoma cells frequently reproduce to keep the tumor alive and help it grow, and the location of glioblastoma in the brain provides the cells with ample blood supply. Through their study of glioblastomas, researchers at Columbia University Medical Center recently discovered that the gene KLHL9 is a leading factor in the cause of glioblastomas.Read More
Columbia University’s medical school is undergoing a groundbreaking transformation in the most literal sense of the word: Construction crews have broken ground on one of two new medical buildings in the works at the powerhouse university’s campus. The new buildings will include teaching space as well as state-of-the-art science research labs.
Research lab scientists at Columbia University received $6.3 million in life science research funding this spring for Columbia’s Center for Research in Diagnostics and Discovery. The research grant was awarded by the administering institute the National Institute of Allergy and Infectious Diseases. The department of Public Health and Preventative Medicine within the Schools of Public Health at Columbia University will use the research funding to advance detection of certain diseases and predict how effective specific therapies can be in prevention and treatment. The Project Information page on the NIH website goes into further detail:
Three researchers at Columbia University recently received NIH awards ranging from $1.9 million to $4 million in life science funding over the next five years. The prizes, part of the Health High Risk-High Reward program, were awarded to researchers whose work suggests highly original approaches to major challenges in biomedical research. The winners are Rafael Yuste, Ozgur Sahin, and Christine Ann Denny.
Columbia University Medical Center administrators recently broke ground at a new medical facility, which will be called the Medical and Graduate Education Building. Columbia University is planning on completing the new medical facility by 2016. Located on Haven Avenue between 171st and 172nd streets in Washington Heights, the building is expected to help resolve the medical center’s space shortages. Architecture firms Diller Scofidio + Renfro and Genseler designed the building, which is described as modern and includes floor-to-ceiling glass windows and a terrace on top of the building with great views of the Hudson River.
Researchers at Columbia University Medical Center recently conducted a study examining brains of a number of different ages donated by people who died without signs of neurologic disease. During the course of the investigation, researchers came to the conclusion that a certain hippocampus gene’s function deteriorates in older people. The researchers believe that age-related memory loss is distinct condition from Alzheimer’s or pre-Alzheimer’s, and that the condition may be treatable in the future.